Abstract
Thyroid function has been assessed in 40 patients with breast cancer and compared with an age-matched control female population. The free thyroxine index was lower and the level of thyroid-stimulating hormone in the serum higher in the cancer group and these changes became more marked at 6 months. It is concluded that patients with breast cancer show more evidence of hypothyroidism as time progresses.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- EDELSTYN G. A., LYONS A. R., WELBOURN R. B. Thyroid function in patients with mammary cancer. Lancet. 1958 Mar 29;1(7022):670–671. doi: 10.1016/s0140-6736(58)91088-2. [DOI] [PubMed] [Google Scholar]
- Eskin B. A. Iodine metabolism and breast cancer. Trans N Y Acad Sci. 1970 Dec;32(8):911–947. doi: 10.1111/j.2164-0947.1970.tb02988.x. [DOI] [PubMed] [Google Scholar]
- Mittra I., Hayward J. L. Hypothalamic-pituitary-thyroid axis in breast cancer. Lancet. 1974 May 11;1(7863):885–889. doi: 10.1016/s0140-6736(74)90344-4. [DOI] [PubMed] [Google Scholar]